Home
Resource
Coencapsulation of insulin-producing cells and mesenchymal stromal cells in PEGDA hydrogels to enhance chronic wound healing
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(3.27 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Aijaz, Ayesha. Coencapsulation of insulin-producing cells and mesenchymal stromal cells in PEGDA hydrogels to enhance chronic wound healing. Retrieved from https://doi.org/doi:10.7282/T3N58Q5P

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleCoencapsulation of insulin-producing cells and mesenchymal stromal cells in PEGDA hydrogels to enhance chronic wound healing
NameAijaz, Ayesha (author); Olabisi, Ronke M (chair); Berthiaume, Francois (internal member); Freeman, Joseph (internal member); Banerjee, Debabrata (outside member); Rutgers University; Graduate School - New Brunswick
Date Created2017
Other Date2017-05 (degree)
SubjectBiomedical Engineering, Wound healing, Wounds and injuries
Extent1 online resource (xii, 120 p. : ill.)
DescriptionWound healing is a hierarchical process of intracellular and intercellular signaling. Insulin is a potent chemoattractant and mitogen for cells involved in wound healing. Insulin’s potential to promote keratinocyte growth and stimulate collagen synthesis in fibroblasts is well described. However, there currently lacks an appropriate delivery mechanism capable of continuously supplying a wound environment with insulin; current approaches require repeated applications of insulin, which increase the chances of infecting the wound. In addition to insulin, exogenous mesenchymal stromal cell or mesenchymal stem cell (MSC) application is a promising treatment strategy for chronic wounds, yet MSC therapies are still far from a clinical reality. MSCs have been shown to improve islet viability and function, regulate inflammation and secrete pro-wound healing factors. MSC-assisted wound healing is elicited through distinct pathways from insulin-assisted wound healing. In this dissertation, a potential synergistic effect of these two differing modes of wound healing was investigated. Since topical insulin creams preclude using MSCs, here insulin-producing cells (IPCs) and MSCs were combined in a dual-cell therapy approach for wound healing. Polyethylene glycol diacrylate (PEGDA) was used to encapsulate IPCs and/or MSCs and results showed that the encapsulation did not alter insulin or MSC secretion profiles. It was hypothesized that MSCs would improve IPC viability and insulin secretion and that the combination of encapsulated IPCs and MSCs would release factors that synergistically accelerate wound repair at greater rates than either cell used alone. The resulting coencapsulated IPC-MSC hydrogel system was applied to a diabetic mouse model of chronic wounds and provided prolonged release of insulin and soluble MSC factors without the need for reapplication. The results showed that IPCs encapsulated within PEGDA hydrogels improved wound healing by 1.6 times, and remarkably IPC and MSC coencapsulation further accelerated wound closure 2.5 times faster, thus supporting the hypothesis. Results further showed increased release of insulin, vascular endothelial growth factor (VEGF), and transforming growth factor β1 (TGF-β1) when IPCs and MSCs were combined than when they were encapsulated singly. Since each of these factors support wound healing, it is unsurprising that wound healing proceeded faster in these groups. In addition, coencapsulated IPCs and MSCs stimulated Akt phosphorylation in myoblasts more than any other treatment group. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway stimulates growth, proliferation, migration and secretion by keratinocytes, endothelial cells and fibroblasts and induces angiogenesis by promoting VEGF secretion. Thus, the PI3-AkT pathway was another pro-wound healing mechanism recruited by the IPC-MSC system. Wounds healed without intermediate scab or scar formation and histology showed mature skin features in IPC-MSC treated wounds. The system’s ability to accelerate healing in chronic wounds with a single application has broad clinical and research implications.
NotePh.D.
NoteIncludes bibliographical references
Noteby Ayesha Aijaz
Genretheses, ETD doctoral
Persistent URLhttps://doi.org/doi:10.7282/T3N58Q5P
Languageeng
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024